ATE448189T1 - Glycerin-peg-derivate als inhibitoren der cyclooxigenase-2 und der phospholipase-a2 - Google Patents
Glycerin-peg-derivate als inhibitoren der cyclooxigenase-2 und der phospholipase-a2Info
- Publication number
- ATE448189T1 ATE448189T1 AT02756086T AT02756086T ATE448189T1 AT E448189 T1 ATE448189 T1 AT E448189T1 AT 02756086 T AT02756086 T AT 02756086T AT 02756086 T AT02756086 T AT 02756086T AT E448189 T1 ATE448189 T1 AT E448189T1
- Authority
- AT
- Austria
- Prior art keywords
- phospholipase
- group
- cyclooxigenase
- glycerin
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
- C08G65/329—Polymers modified by chemical after-treatment with organic compounds
- C08G65/331—Polymers modified by chemical after-treatment with organic compounds containing oxygen
- C08G65/332—Polymers modified by chemical after-treatment with organic compounds containing oxygen containing carboxyl groups, or halides, or esters thereof
- C08G65/3322—Polymers modified by chemical after-treatment with organic compounds containing oxygen containing carboxyl groups, or halides, or esters thereof acyclic
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/02—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
- C07C69/22—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety
- C07C69/30—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety esterified with trihydroxylic compounds
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/926—Topical chemical, e.g. cosmetic or sunscreen
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Emergency Medicine (AREA)
- Nutrition Science (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Detergent Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US27825701P | 2001-03-23 | 2001-03-23 | |
US09/877,334 US6495596B1 (en) | 2001-03-23 | 2001-06-07 | Compounds and methods for inhibition of phospholipase A2 and cyclooxygenase-2 |
PCT/US2002/011155 WO2002102757A1 (en) | 2001-03-23 | 2002-03-22 | Glycerol-peg-derivatives as inhibitors of cyclooxygenase-2 and phospholipase-a2 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE448189T1 true ATE448189T1 (de) | 2009-11-15 |
Family
ID=26959001
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02756086T ATE448189T1 (de) | 2001-03-23 | 2002-03-22 | Glycerin-peg-derivate als inhibitoren der cyclooxigenase-2 und der phospholipase-a2 |
Country Status (6)
Country | Link |
---|---|
US (1) | US6495596B1 (de) |
EP (1) | EP1381587B1 (de) |
AT (1) | ATE448189T1 (de) |
CA (1) | CA2447811C (de) |
DE (1) | DE60234329D1 (de) |
WO (1) | WO2002102757A1 (de) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IS4518A (is) * | 1997-07-09 | 1999-01-10 | Lyfjathroun Hf, The Icelandic Bio Pharmaceutical Group | Nýtt lyfjaform fyrir bóluefni |
US6998421B2 (en) * | 2001-06-07 | 2006-02-14 | Biozone Laboratories, Inc. | Compounds and methods for inhibition of phospholipase A2 and cyclooxygenase - 2 |
WO2003039533A1 (en) * | 2001-11-06 | 2003-05-15 | The Brigham And Women's Hospital, Inc. | Lipoxins and aspirin-triggered lipoxins and their stable analogs in the treatment of asthma and inflammatory airway diseases |
KR20040095232A (ko) * | 2002-02-25 | 2004-11-12 | 라이프자트로운 에이치에프 | 흡수촉진제 |
JP2006518701A (ja) * | 2002-05-24 | 2006-08-17 | ネオファーム、インコーポレイティッド | カルジオリピン組成物、その製造方法及び使用 |
EA200401565A1 (ru) * | 2002-05-24 | 2005-04-28 | Неофарм, Инк. | Способ получения кардиолипина или аналога кардиолипина (варианты), способ получения липосомы и композиция кардиолипина для лечения заболеваний (варианты) |
US6855332B2 (en) * | 2002-07-03 | 2005-02-15 | Lyfjathroun Hf. | Absorption promoting agent |
US20050277611A1 (en) * | 2002-10-16 | 2005-12-15 | Neopharm, Inc. | Cationic cardiolipin analoges and its use thereof |
EP1744767A4 (de) * | 2004-04-20 | 2008-08-13 | Univ Chicago | Therapeutisches abgabesystem mit peg-ähnlicher verbindung mit hohem molekulargewicht |
US20050244367A1 (en) * | 2004-05-03 | 2005-11-03 | Ilypsa, Inc. | Phospholipase inhibitors localized in the gastrointestinal lumen |
US7282224B1 (en) | 2006-06-09 | 2007-10-16 | Guthy-Renker Corporation | Pain relief composition |
US20080107747A1 (en) * | 2006-10-23 | 2008-05-08 | Roederer Joy E | Pain relief composition |
JP5523114B2 (ja) * | 2007-03-08 | 2014-06-18 | モコ セラピューティクス エルエルシー | 傷跡が残ることを防止する及び減少させる被覆製剤 |
MX2010008891A (es) * | 2008-02-20 | 2011-06-01 | Elc Man Llc | Composiciones topicas y metodos para blanquear la piel. |
EP2451280A4 (de) * | 2009-07-09 | 2012-12-26 | Crescendo Therapeutics Llc | Verfahren für wundheilung und narbenmodulierung |
CN106290351A (zh) * | 2015-06-03 | 2017-01-04 | 舒泰神(北京)生物制药股份有限公司 | 一种磷脂酶a2的活性测定方法 |
US10702475B2 (en) | 2017-09-05 | 2020-07-07 | Richard Rigg | Liposome containing compositions and their use in personal care and food products |
JP6805385B1 (ja) * | 2020-08-31 | 2020-12-23 | ジェイ−ネットワーク,インコーポレイテッド | 表皮内の保湿関連物質の発現増強剤 |
JP6860739B1 (ja) * | 2020-11-20 | 2021-04-21 | ジェイ−ネットワーク,インコーポレイテッド | 表皮内の抗酸化物質の発現増強剤 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5001234A (en) | 1987-04-16 | 1991-03-19 | The Upjohn Company | Cyclic hydrocarbons with an aminoalkyl sidechain |
US5659049A (en) | 1988-02-18 | 1997-08-19 | Virginia Commonwealth University | Antioxidant, antiphospholipase derivatives of ricinoleic acid |
US5122536A (en) | 1989-10-12 | 1992-06-16 | Perricone Nicholas V | Method for the topical treatment of psoriasis |
JPH04134077A (ja) | 1990-09-21 | 1992-05-07 | Taiho Yakuhin Kogyo Kk | イソオキサゾール化合物 |
EP0543417A1 (de) | 1991-11-22 | 1993-05-26 | Lipogenics, Incorporated | Tocotrienole und Focotrienol-ähnliche Verbindungen und Verfahren zu ihrer Verwendung |
US5451686A (en) | 1994-04-15 | 1995-09-19 | Allergan, Inc. | 3 and 5 alkyl and phenyl 4-(hydroxy or acyloxy)-alkyl substituted 2(5H)-furanones as anti-inflammatory agents |
FR2750426B1 (fr) | 1996-06-28 | 1998-08-07 | Cird Galderma | Nouveaux composes biaryles heterocycliques et leur utilisation en medecine humaine ou veterinaire ainsi qu'en cosmetique |
US5863560A (en) | 1996-09-11 | 1999-01-26 | Virotex Corporation | Compositions and methods for topical application of therapeutic agents |
US6060082A (en) | 1997-04-18 | 2000-05-09 | Massachusetts Institute Of Technology | Polymerized liposomes targeted to M cells and useful for oral or mucosal drug delivery |
DE19909552C1 (de) * | 1999-03-04 | 2000-07-27 | Goldwell Gmbh | Haarwaschmittel |
-
2001
- 2001-06-07 US US09/877,334 patent/US6495596B1/en not_active Expired - Lifetime
-
2002
- 2002-03-22 EP EP02756086A patent/EP1381587B1/de not_active Expired - Lifetime
- 2002-03-22 DE DE60234329T patent/DE60234329D1/de not_active Expired - Lifetime
- 2002-03-22 AT AT02756086T patent/ATE448189T1/de not_active IP Right Cessation
- 2002-03-22 CA CA2447811A patent/CA2447811C/en not_active Expired - Fee Related
- 2002-03-22 WO PCT/US2002/011155 patent/WO2002102757A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
US20020198260A1 (en) | 2002-12-26 |
EP1381587A1 (de) | 2004-01-21 |
WO2002102757A1 (en) | 2002-12-27 |
EP1381587B1 (de) | 2009-11-11 |
US6495596B1 (en) | 2002-12-17 |
DE60234329D1 (de) | 2009-12-24 |
CA2447811C (en) | 2011-11-29 |
CA2447811A1 (en) | 2002-12-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE448189T1 (de) | Glycerin-peg-derivate als inhibitoren der cyclooxigenase-2 und der phospholipase-a2 | |
DE60027135D1 (de) | Inhibitoren für wachstumdifferenzierungsfaktor und ihre anwendungen | |
MA31167B1 (fr) | Inhibiteurs de l'activite de akt | |
DK1754707T3 (da) | Multicykliske forbindelser og anvendelse deraf som inhibitorer af PARP-, VEGFR2- og MLK3-enzymer | |
MXPA05010711A (es) | Compuestos y composiciones novedosos como inhibidores de proteina-quinasa. | |
PT1206474E (pt) | Compostos de sulfonilfenilpirazole uteis como inibidores de cox-2 | |
MY142589A (en) | Benzimidazole derivatives : preparation and pharmaceutical applications | |
BRPI0518228B8 (pt) | inibidores de cinesina mitótica e uso dos mesmos | |
BRPI0514395A (pt) | uso terapêutico de inibidores de rtp801 | |
ATE463490T1 (de) | Histondeacetylase-hemmer | |
PT1261600E (pt) | Derivados heteroaromaticos de carboxamida e sua utilizacao como inibidores do enzima ikk-2 | |
ATE489360T1 (de) | Inhibitoren der histon-deacetylase | |
ECSP045520A (es) | Metodos de tratamiento con inhibidores de la ptec y agentes antihipertensivos | |
NO20014986L (no) | 4,5-diaryl-3(2H)-furanonderivater som cyklooksygenase-2- inhibitorer | |
MX2008010462A (es) | Inhibidores de histona desacetilasa. | |
DE60319158D1 (de) | Pyrazoloisoquinolinenderivaten als kinase inhibitoren | |
EA201100604A1 (ru) | Соединения пиридиловых ингибиторов передачи сигналов белком hedgehog, способ их получения, композиция и способы лечения рака и ингибирований ангиогенеза и сигнального пути hedgehog в клетках на их основе | |
DK0971713T3 (da) | Anvendelse af cholinesteraseinhibitorer til behandling af opmærksomhedsforstyrrelser | |
CR20110016A (es) | Compuestos quimicos 251 | |
UY27362A1 (es) | Métodos de usar inhibidores de epóxido hidrolasa soluble | |
BRPI0514549A (pt) | ácidos de pirrol-naftila como inibidores de pai-1 | |
BRPI0507626A (pt) | compostos e composiçoes como moduladores de lxr | |
UY30918A1 (es) | Moduladores de lta4h y sus usos | |
ATE452884T1 (de) | Arylmethylamin-derivate zur verwendung als inhibitoren von tryptase | |
ATE472998T1 (de) | Kationische liposomale zubereitungen zur behandlung von rheumatoider arthritis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |